drugset / Trial / NCT01717391

[F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers

NCT01717391

NaSingle-groupOpen-labelTreatment

Summary

\[F-18\] Fluorothymidine PET imaging will be used to create a radiation therapy treatment plan to avoid active bone marrow in the pelvis. This will be done to evaluate if sparing bone marrow will help maintain blood counts. This would impact chemotherapy administration.

Timeline

Start
2012-10-01
Primary completion
2016-02-29
Completion
2017-04-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject 18F-FLT Diagnostic / imaging agent